Post

New research · Urology
International urogynecology journal · 17h
ReviewInternational urogynecology journal · 2026

Long-Term Outcomes of Midurethral Slings: A Narrative Review of Objective and Patient-Reported Trajectories.

Elif Nazli Cetindag, Ahmet Ozgur Yeniel
Read paper
UrologyReview

Overactive bladder newly appears in many women years after sling surgery

Long-Term Outcomes of Midurethral Slings: A Narrative Review of Objective and Patient-Reported Trajectories.

Elif Nazli Cetindag et al. · International urogynecology journal · 2026
Background

Midurethral sling (MUS) procedures are widely used for stress urinary incontinence (SUI), yet long-term outcomes remain incompletely characterized.

Purpose

Cure rates exceeded 85-90% at 10 years and remained stable in retropubic cohorts.

Methods

Randomized trials and observational studies were included.

41.6%
Results
Share with new overactive bladder (sudden urgency, frequent urination) at 20 years
More results

Subjective cure rates were more variable and declined in some cohorts despite preserved objective outcomes.

“
Conclusion · 1 of 2

MUS procedures provide durable long-term structural continence. However, patient-perceived outcomes may evolve due to storage symptoms, particularly de novo OAB, and late complications.

Conclusion · 2 of 2

Although voiding dysfunction may contribute to long-term symptom burden, its role remains insufficiently characterized in the available literature. Longitudinal, domain-specific assessment beyond binary continence measures is needed.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
HR 1.87
lower muscle quality means nearly twice the risk of dying from advanced prostate cancer
Cross-sectional
71.8%
most urologists never used a standard survey to assess stent symptoms
Cohort Study
SIR 1.67
young bladder cancer survivors have a higher risk of developing second cancers compared to the general population
Cohort Study
98%
98% of patients had no significant rectocele after laparoscopic double sacrocolpopexy.
Cohort Study
OR 0.10
Beyond 4000 J/ml, the odds of reintervention are 90% lower.
Randomized Trial
hazard ratio 0·67
pirarubicin instillation led to a lower risk of recurrence compared to observation
Study
3,216
This many specific enhancers were found in prostate cancer cells, not normal cells.
Case-control
OR = 4.23
Higher triglycerides linked to higher odds of prostate cancer (odds, not risk)